Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: SKIN NEOPLASMS - IMMUNOLOGY , . Treffer: 61

2017

Ritter, C; Fan, K; Paschen, A; Reker Hardrup, S; Ferrone, S; Nghiem, P; Ugurel, S; Schrama, D; Becker, JC Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma.
Sci Rep. 2017; 7(1):2290-2290 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Garg, K; Maurer, M; Griss, J; Brüggen, MC; Wolf, IH; Wagner, C; Willi, N; Mertz, KD; Wagner, SN Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
Hum Pathol. 2016; 54(6):157-164
Web of Science PubMed FullText FullText_MUG

 

Kash, N; Massone, C; Fink-Puches, R; Cerroni, L Phenotypic Variation in Different Lesions of Mycosis Fungoides Biopsied Within a Short Period of Time From the Same Patient.
Am J Dermatopathol. 2016; 38(7):541-545 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Reggiani, C; Massone, C; Fink-Puches, R; Cota, C; Cerroni, L Interstitial Mycosis Fungoides: A Clinicopathologic Study of 21 Patients.
Am J Surg Pathol. 2016; 40(10):1360-1367
Web of Science PubMed FullText FullText_MUG

 

Richtig, E; Trapp, M; Kapfhammer, HP; Jenull, B; Richtig, G; Trapp, EM The Importance of a Biopsychosocial Approach in Melanoma ResearchExperiences from a Single-center Multidisciplinary Melanoma Working Group in Middle-Europe.
Acta Derm Venereol. 2016; 96(217):51-54 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ritter, C; Fan, K; Paulson, KG; Nghiem, P; Schrama, D; Becker, JC Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma.
Sci Rep. 2016; 6:21678-21678 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Trapp, EM; Trapp, M; Avian, A; Rohrer, PM; Weissenböck, T; Kapfhammer, HP; Demel, U; Linder, MD; Kresse, A; Richtig, E Association of Stress Coping Strategies with Immunological Parameters in Melanoma Patients.
ACTA DERM-VENEREOL. 2016; 96(217): 74-77. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Walsh, NM; Fleming, KE; Hanly, JG; Dakin Hache, K; Doucette, S; Ferrara, G; Cerroni, L A morphological and immunophenotypic map of the immune response in Merkel cell carcinoma.
Hum Pathol. 2016; 52(6):190-196
Web of Science PubMed FullText FullText_MUG

 

2015

Bosisio, FM; Cerroni, L Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
Am J Dermatopathol. 2015; 37(2):115-121
Web of Science PubMed FullText FullText_MUG

 

Ferrara, G; Ena, L; Cota, C; Cerroni, L Intralymphatic Spread Is a Common Finding in Cutaneous CD30+ Lymphoproliferative Disorders.
Am J Surg Pathol. 2015; 39(11):1511-1517
Web of Science PubMed FullText FullText_MUG

 

Richtig, E; Trapp, EM; Avian, A; Brezinsek, HP; Trapp, M; Egger, JW; Kapfhammer, HP; Rohrer, PM; Berghold, A; Curiel-Lewandrowski, C; Demel, U Psychological Stress and Immunological Modulations in Early-stage Melanoma Patients.
Acta Derm Venereol. 2015; 95(6):691-695 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Oliveira, A; Arzberger, E; Massone, C; Fink-Puches, R; Zalaudek, I; Hofmann-Wellenhof, R Dermoscopy, reflectance confocal microscopy and immunohistochemical analysis in melanocytic lesions with Meyerson's phenomenon.
Dermatology. 2014; 229(4):297-305 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Paulson, KG; Tegeder, A; Willmes, C; Iyer, JG; Afanasiev, OK; Schrama, D; Koba, S; Thibodeau, R; Nagase, K; Simonson, WT; Seo, A; Koelle, DM; Madeleine, M; Bhatia, S; Nakajima, H; Sano, S; Hardwick, JS; Disis, ML; Cleary, MA; Becker, JC; Nghiem, P Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma.
Cancer Immunol Res. 2014; 2(11):1071-1079 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Weide, B; Eigentler, TK; Pflugfelder, A; Zelba, H; Martens, A; Pawelec, G; Giovannoni, L; Ruffini, PA; Elia, G; Neri, D; Gutzmer, R; Becker, JC; Garbe, C Intralesional treatment of stage III metastatic melanoma patients with L19-IL2 results in sustained clinical and systemic immunologic responses.
Cancer Immunol Res. 2014; 2(7):668-678 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Doedens, AL; Phan, AT; Stradner, MH; Fujimoto, JK; Nguyen, JV; Yang, E; Johnson, RS; Goldrath, AW Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen.
Nat Immunol. 2013; 14(11):1173-1182 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kruit, WH; Suciu, S; Dreno, B; Mortier, L; Robert, C; Chiarion-Sileni, V; Maio, M; Testori, A; Dorval, T; Grob, JJ; Becker, JC; Spatz, A; Eggermont, AM; Louahed, J; Lehmann, FF; Brichard, VG; Keilholz, U Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma.
J Clin Oncol. 2013; 31(19): 2413-2420. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rodríguez-Pinilla, SM; Ortiz-Romero, PL; Monsalvez, V; Tomás, IE; Almagro, M; Sevilla, A; Camacho, G; Longo, MI; Pulpillo, Á; Diaz-Pérez, JA; Montes-Moreno, S; Castro, Y; Echevarría, B; Trébol, I; Gonzalez, C; Sánchez, L; Otín, AP; Requena, L; Rodríguez-Peralto, JL; Cerroni, L; Piris, MÁ TCR-γ expression in primary cutaneous T-cell lymphomas.
Am J Surg Pathol. 2013; 37(3):375-384
Web of Science PubMed FullText FullText_MUG

 

2012

Becker, JC; Andersen, MH; Hofmeister-Muller, V; Wobser, M; Frey, L; Sandig, C; Walter, S; Singh-Jasuja, H; Kampgen, E; Opitz, A; Zapatka, M; Brocker, EB; Straten, PT; Schrama, D; Ugurel, S; Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma.
Cancer Immunol Immunother. 2012; 61(11):2091-2103 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kempf, W; Kazakov, DV; Palmedo, G; Fraitag, S; Schaerer, L; Kutzner, H; Pityriasis Lichenoides et Varioliformis Acuta With Numerous CD30(+) Cells A Variant Mimicking Lymphomatoid Papulosis and Other Cutaneous Lymphomas. A Clinicopathologic, Immunohistochemical, and Molecular Biological Study of 13 Cases.
Am J Surg Pathol. 2012; 36(7):1021-1029 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Willmes, C; Adam, C; Alb, M; Völkert, L; Houben, R; Becker, JC; Schrama, D Type I and II IFNs inhibit Merkel cell carcinoma via modulation of the Merkel cell polyomavirus T antigens.
Cancer Res. 2012; 72(8): 2120-2128. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Paulson, KG; Iyer, JG; Tegeder, AR; Thibodeau, R; Schelter, J; Koba, S; Schrama, D; Simonson, WT; Lemos, BD; Byrd, DR; Koelle, DM; Galloway, DA; Leonard, JH; Madeleine, MM; Argenyi, ZB; Disis, ML; Becker, JC; Cleary, MA; Nghiem, P Transcriptome-Wide Studies of Merkel Cell Carcinoma and Validation of Intratumoral CD8+ Lymphocyte Invasion As an Independent Predictor of Survival
J CLIN ONCOL. 2011; 29(12): 1539-1546. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

2010

Ferrara, G; Crisman, G; Zalaudek, I; Argenziano, G; Stefanato, CM Free-floating collagen fibers in interstitial mycosis fungoides.
Am J Dermatopathol. 2010; 32(4):352-356
Web of Science PubMed FullText FullText_MUG

 

Kempf, W; Kerl, H; Kutzner, H CD123-Positive Plasmacytoid Dendritic Cells in Primary Cutaneous Marginal Zone B-Cell Lymphoma: A Crucial Role and a New Lymphoma Paradigm.
Am J Dermatopathol. 2010; 32(2): 194-196. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Paulson, KG; Carter, JJ; Johnson, LG; Cahill, KW; Iyer, JG; Schrama, D; Becker, JC; Madeleine, MM; Nghiem, P; Galloway, DA Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients.
Cancer Res. 2010; 70(21): 8388-8397. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

2009

Beltraminelli, H; Leinweber, B; Kerl, H; Cerroni, L Primary cutaneous CD4+ small-/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases.
Am J Dermatopathol. 2009; 31(4): 317-322.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Hofmeister-Mueller, V; Vetter-Kauczok, CS; Ullrich, R; Meder, K; Lukanidin, E; Broecker, EB; Straten, PT; Andersen, MH; Schrama, D; Becker, JC Immunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patients.
Cancer Immunol Immunother. 2009; 58(8):1265-1273 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Knobler, R; Barr, ML; Couriel, DR; Ferrara, JL; French, LE; Jaksch, P; Reinisch, W; Rook, AH; Schwarz, T; Greinix, H Extracorporeal photopheresis: past, present, and future.
J Am Acad Dermatol. 2009; 61(4): 652-665.
Web of Science PubMed FullText FullText_MUG

 

Leinweber, B; Beltraminelli, H; Kerl, H; Cerroni, L Solitary small- to medium-sized pleomorphic T-cell nodules of undetermined significance: clinical, histopathological, immunohistochemical and molecular analysis of 26 cases.
Dermatology. 2009; 219(1): 42-47.
Web of Science PubMed FullText FullText_MUG

 

Straten, PT; Becker, JC Adoptive cell transfer in the treatment of metastatic melanoma.
J Invest Dermatol. 2009; 129(12):2743-2745 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2008

Houben, R; Wischhusen, J; Menaa, F; Synwoldt, P; Schrama, D; Brocker, EB; Becker, JC Melanoma stem cells: targets for successful Therapy?
J DTSCH DERMATOL GES. 2008; 6(7): 541-547.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Massone, C; Crisman, G; Kerl, H; Cerroni, L The prognosis of early mycosis fungoides is not influenced by phenotype and T-cell clonality.
Br J Dermatol. 2008; 159(4): 881-886.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2006

Dejaco, C; Duftner, C; Schirmer, M Induction of tolerance in autoimmune diseases rather than cure of cancer by interleukin-2 therapy.
J Clin Oncol. 2006; 24(20): e34; author reply e35-e34; author reply e36. [OPEN ACCESS]
PubMed FullText FullText_MUG

 

Fensterle, J; Trefzer, U; Berger, T; Andersen, MH; Ugurel, S; Becker, JC HLA-B8 association with late-stage melanoma - an immunological lesson?
BMC MED. 2006; 4: [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pashenkov, M; Goëss, G; Wagner, C; Hörmann, M; Jandl, T; Moser, A; Britten, CM; Smolle, J; Koller, S; Mauch, C; Tantcheva-Poor, I; Grabbe, S; Loquai, C; Esser, S; Franckson, T; Schneeberger, A; Haarmann, C; Krieg, AM; Stingl, G; Wagner, SN Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma.
J CLIN ONCOL. 2006; 24(36): 5716-5724. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Straten, PT; Dahl, C; Schrama, D; Pedersen, LO; Andersen, MH; Seremet, T; Brocker, EB; Guldberg, P; Becker, JC Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes.
Cancer Immunol Immunother. 2006; 55(5):495-502
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Voigt, H; Schrama, D; Eggert, AO; Vetter, CS; Muller-Blech, K; Reichardt, HM; Andersen, MH; Becker, JC; Luhder, F CD28-mediated costimulation impacts on the differentiation of DC vaccination-induced T cell responses.
Clin Exp Immunol. 2006; 143(1):93-102 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2005

Becker, JC; Straten, PT; Andersen, MH The paradoxical association between Bcl-2 expression and prognosis: does the immune system make the difference?
Cancer Res. 2005; 65(7):2983-2983 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Fourtanier, A; Moyal, D; Maccario, J; Compan, D; Wolf, P; Quehenberger, F; Cooper, K; Baron, E; Halliday, G; Poon, T; Seed, P; Walker, SL; Young, AR Measurement of sunscreen immune protection factors in humans: a consensus paper.
J INVEST DERMATOL. 2005; 125(3): 403-409. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2004

Andersen, MH; Fensterle, J; Ugurel, S; Reker, S; Houben, R; Guldberg, P; Berger, TG; Schadendorf, D; Trefzer, U; Brocker, EB; Straten, PT; Rapp, UR; Becker, JC Immunogenicity of constitutively active (V599E)BRaf
CANCER RES. 2004; 64(15): 5456-5460. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Berger, TG; Haendle, I; Schrama, D; Luftl, M; Bauer, N; Pedersen, LO; Schuler-Thurner, B; Hohenberger, W; Straten, PT; Schuler, G; Becker, JC Circulation and homing of melanoma-reactive T cells to both cutaneous and visceral metastases after vaccination with monocyte-derived dendritic cells
INT J CANCER. 2004; 111(2): 229-237. (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Schrama, D; Rong, XA; Eggert, AO; Andersen, MH; Pedersen, LO; Kampgen, E; Schumacher, TN; Reisfeld, RR; Becker, JC Shift from systemic to site-specific memory by tumor-targeted IL-2
J IMMUNOL. 2004; 172(10): 5843-5850. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Ugurel, S; Uhlig, D; Pföhler, C; Tilgen, W; Schadendorf, D; Reinhold, U Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients.
Cancer Immunol Immunother. 2004; 53(6):551-559
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2003

Andersen, MH; Gehl, J; Reker, S; Pedersen, LO; Becker, JC; Geertsen, P; Straten, PT Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration.
Semin Cancer Biol. 2003; 13(6):449-459
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Schrama, D; Eggert, AAO; Brocker, EB; Pedersen, LO; Straten, PT; Becker, JC Immunological consequences of the sentinel lymph-node biopsy - lessons from a melanoma patient
LANCET ONCOL. 2003; 4(7): 446-447. (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Ugurel, S; Schadendorf, D Systemic treatment in advanced melanoma: innovative perspectives.
Onkologie. 2003; 26(3):234-238
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2002

Pedersen, LO; Vetter, CS; Mingari, MC; Andersen, MH; Straten, PT; Brocker, EB; Becker, JC Differential expression of inhibitory or activating CD94/NKG2 subtypes on MART-1-reactive T cells in vitiligo versus melanoma: a case report.
J Invest Dermatol. 2002; 118(4):595-599 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Schrama, D; Pedersen, LO; Keikavoussi, P; Andersen, MH; Straten, PT; Brocker, EB; Kampgen, E; Becker, JC Aggregation of antigen-specific T cells at the inoculation site of mature dendritic cells.
J Invest Dermatol. 2002; 119(6):1443-1448 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Ugurel, S; Reinhold, U; Tilgen, W HLA-G in melanoma: A new strategy to escape from immunosurveillance?
Onkologie. 2002; 25(2):129-134
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Vetter, CS; Groh, V; Straten, PT; Spies, T; Brocker, EB; Becker, JC Expression of stress-induced MHC class I related chain molecules on human melanoma.
J Invest Dermatol. 2002; 118(4):600-605 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2001

Ugurel, S; Rebmann, V; Ferrone, S; Tilgen, W; Grosse-Wilde, H; Reinhold, U Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy.
Cancer. 2001; 92(2):369-376
Web of Science PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum